HCID 178455973, 화합물 → HCID 178455964, 화합물

HRID 365056노트

반응식

HRID 365056 반응식
[NH:1](C(OC(C)(C)C)=O)[C@H:2]([C:7]([NH:9][C@H:10]([C:22]([NH:24][C@H:25]([C:36]([NH:38][C@H:39]([C:44]([NH:46][CH2:47][C:48]([O:50][CH3:51])=[O:49])=[O:45])[C@H:40]([CH2:42][CH3:43])[CH3:41])=[O:37])[CH2:26][CH2:27][CH2:28][NH:29][C:30](=[NH:35])[NH:31][N+:32]([O-:34])=[O:33])=[O:23])[CH2:11][C:12](=[O:21])[O:13][CH2:14][C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1)=[O:8])[C@H:3]([CH2:5][CH3:6])[CH3:4]>CCOC(C)=O>[NH2:1][C@H:2]([C:7]([NH:9][C@H:10]([C:22]([NH:24][C@H:25]([C:36]([NH:38][C@H:39]([C:44]([NH:46][CH2:47][C:48]([O:50][CH3:51])=[O:49])=[O:45])[C@H:40]([CH2:42][CH3:43])[CH3:41])=[O:37])[CH2:26][CH2:27][CH2:28][NH:29][C:30](=[NH:35])[NH:31][N+:32]([O-:34])=[O:33])=[O:23])[CH2:11][C:12](=[O:21])[O:13][CH2:14][C:15]1[CH:16]=[CH:17][CH:18]=[CH:19][CH:20]=1)=[O:8])[C@H:3]([CH2:5][CH3:6])[CH3:4]

참가 물질

3

반응물 1

HCID 178455973HCID 178455973, 화합물

생성물 1

HCID 178455964HCID 178455964, 화합물

시약·촉매·용매 1

HCID 8857Ethyl Acetate용매

실험 절차

A sample of the pentapeptide (12) suspended in EtOAc is treated exactly as described for the preparation of tetrapeptide HCl salt (11) to give product (13).

후처리

  1. additionis treated exactly

출처 및 근거

ORD 기록
ord-030d3c5b0fed4572b25e2d7bb441dc9c
출처 데이터셋
uspto-grants-1986_08
특허 번호
US04607023

반응 노트

불러오는 중…